CHERRY HILL, N.J., June 10 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), an emerging healthcare consumer products company, today announced that its recent marketing success with the Cinnergen product earned a Spotlight Stock feature on the Wall Street Reporter.com (www.wallstreetreporter.com).
In a recorded interview, Martin Schmieg, Chairman and CEO of Nuvilex, Inc. offers background on the company, its management team and near-term product plans.
About the Wall Street Reporter
The Wall Street Reporter is a multi-media financial research and publishing company reporting to the investment community on publicly held companies since 1843. A large following of sophisticated private and institutional investors looks to the WSR to identify promising under-valued small and micro cap opportunities before the rest of the market finds them. Today the WSR reaches into the investment community across markets and continents and includes print, web, audio, streaming video, email alerts, electronic and syndicated news story distribution (including FOX and MSNBC, Money Central, Investing/Business Week), investor conferences, and CFA analyst coverage.
About Nuvilex, Inc.
Nuvilex, formerly eFoodSafety.com, is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercializing healthcare products that address the health needs of consumers worldwide. In March 2009, Nuvilex merged wit
|SOURCE Nuvilex, Inc.|
Copyright©2009 PR Newswire.
All rights reserved